Expert Commentary: The Safety of Fibrates in Lipid-Lowering Therapy-Reference-Cited by-同舟云学术

Expert Commentary: The Safety of Fibrates in Lipid-Lowering Therapy

Published:2007-03 Issue:6 Volume:99 Page:S19-S21
ISSN:0002-9149
Container-title:The American Journal of Cardiology
language:en
Short-container-title:The American Journal of Cardiology

Author:

Brown W. Virgil

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine

Reference28 articles.

1. Fatty acids, eicosanoids, and hypolipidemic agents identified as ligands of peroxisome proliferator-activated receptors by coactivator-dependent receptor ligand assay;Krey;Mol Endocrinol,1997

2. PPAR- and LXR-dependent pathways controlling lipid metabolism and the development of atherosclerosis;Li;J Lipid Res,2004

3. Results of atromid or CPIB treatment with and without androsterone in hyperlipemia (110 therapeutic trials in 2 years);de Gennes;Bull Mem Soc Med Hop Paris,1965

4. Treatment of hypercholesterolemia with fenofibrate: a review;Brown;Curr Med Res Opin,1987

5. Effects of fenofibrate on plasma lipids: double blind, multicenter study in patients with type IIA or IIB hyperlipidemia;Brown;Arteriosclerosis,1986

Cited by 28 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Targeting autophagy in diabetic cardiomyopathy: From molecular mechanisms to pharmacotherapy;Biomedicine & Pharmacotherapy;2024-06

2. Atherosclerosis: The Involvement of Immunity, Cytokines and Cells in Pathogenesis, and Potential Novel Therapeutics;Aging and disease;2022

3. Prevalence of and Factors Associated With the Prescription of Fibrates Among Patients Receiving Lipid-Lowering Drugs in Germany;Journal of Cardiovascular Pharmacology;2021-12

4. Fenofibrate Inhibits Subretinal Fibrosis Through Suppressing TGF‐β—Smad2/3 signaling and Wnt signaling in Neovascular Age‐Related Macular Degeneration;Frontiers in Pharmacology;2020-11-17

5. Genetic Influences on Blood Lipids and Cardiovascular Disease Risk;Nutrition in the Prevention and Treatment of Disease;2017